Dr. Colwyn “CoCo” Headley is a mitochondria expert and a Postdoctoral Fellow at Stanford University’s Cardiovascular Institute, conducting research under the mentorship of Dr. Philip Tsao. Blending his longstanding interests in aging-associated mitochondrial dysfunction and immunity, Dr. Headley draws upon Dr. Tsao’s expertise in cardiovascular disease to advance our understanding of the immune-cardiovascular axis. A key area of his research is to reveal novel perspectives on how the immune system interacts with cardiovascular health as we age.
Dr. Headley earned his B.S. in Microbiology and later completed his Ph.D. in Biomedical Sciences with a focus on Immunology, both at The Ohio State University. During his doctoral research in Dr. Joanne Turner’s lab, he explored the impact of biological aging on adaptive immunity, examining how aging influences immune responses and identifying potential strategies to boost immune function in older adults.
Known for his innovative research in longevity and mitochondrial health, Dr. Headley’s contributions are widely recognized in the scientific community. His publication, Mitochondrial Replacement Therapy to Treat Aging-associated Immune Dysregulations, has been celebrated as a groundbreaking study that explores new ways to treat immune dysfunction in aging. His work continues to push boundaries in the fields of immunity and cardiovascular health, offering promising insights to pave the way for new treatments.
